O’Brien, J., Ramaker, R. C., Moyer, A., Strickler, J. H., Tong, B. C., Ramaker, M. E., … Clarke, J. M. (2026). Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States. JCO Precision Oncology, 10, e2600139. https://doi.org/10.1200/po-26-00139

O’Brien, Jenny, Ryne C. Ramaker, Ashley Moyer, John H. Strickler, Betty C. Tong, Megan E. Ramaker, Svati H. Shah, Laura Alder, Thomas E. Stinchcombe, and Jeffrey M. Clarke. “Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States.” JCO Precision Oncology 10 (March 2026): e2600139. https://doi.org/10.1200/po-26-00139.

O’Brien J, Ramaker RC, Moyer A, Strickler JH, Tong BC, Ramaker ME, et al. Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States. JCO precision oncology. 2026 Mar;10:e2600139.

O’Brien, Jenny, et al. “Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States.” JCO Precision Oncology, vol. 10, Mar. 2026, p. e2600139. Epmc, doi:10.1200/po-26-00139.

O’Brien J, Ramaker RC, Moyer A, Strickler JH, Tong BC, Ramaker ME, Shah SH, Alder L, Stinchcombe TE, Clarke JM. Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States. JCO precision oncology. 2026 Mar;10:e2600139.